Peter McAllister, MD: Lack of Treatment For Post-Stroke Spasticity
July 28th 2020The medical director of the New England Institute for Neurology and Headache and chief medical officer of the New England Institute for Clinical Research detailed the lack awareness and options for those who suffer from upper limb spasticity following a stroke.
Ped-MSSS May Serve as Alternative to EDSS in Pediatric-Onset MS
July 28th 2020The findings indicate that the use of a MS severity score (Ped-MSSS) model may provide an alternative to EDSS scoring, which has been shown to be lower in pediatric disease, in clinical assessment of disease severity and disability accrual.
DaxibotulinumtoxinA Aims to Be Next Big Post-Stroke Spasticity Treatment
July 27th 2020The medical director of the New England Institute for Neurology and Headache and chief medical officer of the New England Institute for Clinical Research discussed the recent phase 2 JUNIPER upper limb spasticity trial of daxibotulinumtoxinA for injection.
Jeffrey Cummings, MD, ScD: Trends in the Alzheimer Disease Clinical Pipeline
July 24th 2020The director emeritus of the Lou Ruvo Center for Brain Health at Cleveland Clinic and vice chair of the Department of Brain Health at the University of Nevada-Las Vegas, details trends in Alzheimer disease research over the past few years.
Hubert Fernandez, MD: Raising Awareness For Parkinson Disease on World Brain Day
July 22nd 2020The director of the Center for Neurological Restoration at Cleveland Clinic discussed the importance of raising awareness of Parkinson disease on World Brain Day, highlighting the magnitude of the disease.
Matthew Robbins, MD: Headaches Associated With COVID-19
July 21st 2020The director of the Neurology Residency Program at Weill Cornell Medicine highlighted some of the differences in types of headaches that patients with COVID-19 experience, as well as overall takeaways from the pandemic itself.